Factor Bioscience Inc. 13D and 13G filings for BROOKLYN IMMUNO THERAPEUTICS L:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-08-27 5:26 pm Purchase | 2021-08-27 | 13G | Eterna Therapeutics Inc. ERNA | Factor Bioscience Inc. | 15,570 9.000% | 15,570 (New Position) | Filing |